Literature DB >> 26327300

Value of third-trimester cerebroplacental ratio and uterine artery Doppler indices as predictors of stillbirth and perinatal loss.

A Khalil1, J Morales-Roselló1, R Townsend1, M Morlando1, A Papageorghiou1, A Bhide1, B Thilaganathan1.   

Abstract

OBJECTIVE: Placental insufficiency contributes to the risk of stillbirth. Cerebroplacental ratio (CPR) is an emerging marker of placental insufficiency. The aim of this study was to evaluate the association of third-trimester fetal CPR, uterine artery (UtA) Doppler and estimated fetal weight (EFW) with stillbirth and perinatal death.
METHODS: This was a retrospective cohort study including 2812 women with a singleton pregnancy who underwent an ultrasound scan in the third trimester. EFWs were converted into centiles, and Doppler indices (UtA and CPR) were converted into multiples of the median (MoM), adjusting for gestational age. Regression analysis was performed to identify, and adjust for, potential confounders, and receiver-operating characteristics (ROC) curve analysis was used to assess the predictive value.
RESULTS: When adjusting for EFW centile and UtA mean pulsatility index (UtA-PI) MoM, CPR-MoM remained an independent predictor of stillbirth (odds ratio (OR) = 0.003 (95% CI, 0.00-0.11), P = 0.003) and perinatal mortality (OR = 0.001 (95% CI, 0.00-0.03), P < 0.001). UtA-PI ≥ 1.5 MoM was significantly associated with low CPR-MoM, even after adjusting for EFW centile (OR = 5.22 (95% CI, 3.88-7.04), P < 0.001) or small-for-gestational age (SGA; OR = 4.73 (95% CI, 3.49-6.41), P < 0.001). These associations remained significant, even when excluding pregnancies with SGA or including only cases in which Doppler indices were recorded at term (P < 0.01). For prediction of stillbirth, the area under the ROC curve, using a combination of these three parameters, was 0.88 (95% CI, 0.77-0.99) with a sensitivity of 66.7%, specificity of 92.1%, positive likelihood ratio (LR) of 8.46 and negative LR of 0.36.
CONCLUSIONS: Third-trimester CPR is an independent predictor of stillbirth and perinatal mortality. The role of UtA Doppler, CPR and EFW in assessing risk of adverse pregnancy outcome should be evaluated prospectively.
Copyright © 2015 ISUOG. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  birth weight; cerebroplacental ratio; perinatal death; stillbirth; uterine artery Doppler

Mesh:

Year:  2016        PMID: 26327300     DOI: 10.1002/uog.15729

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  22 in total

1.  A Low Cerebroplacental Ratio at 20-24 Weeks of Gestation Can Predict Reduced Fetal Size Later in Pregnancy or at Birth.

Authors:  Edgar Hernandez-Andrade; Eli Maymon; Offer Erez; Homam Saker; Suchaya Luewan; Maynor Garcia; Hyunyoung Ahn; Adi L Tarca; Bogdan Done; Steven J Korzeniewski; Sonia S Hassan; Roberto Romero
Journal:  Fetal Diagn Ther       Date:  2017-09-20       Impact factor: 2.587

2.  New Markers for Placental Dysfunction at Term - Potential for More.

Authors:  Oliver Graupner; Bettina Kuschel; Roland Axt-Fliedner; Christian Enzensberger
Journal:  Geburtshilfe Frauenheilkd       Date:  2022-07-07       Impact factor: 2.754

Review 3.  Clinical Opinion: The diagnosis and management of suspected fetal growth restriction: an evidence-based approach.

Authors:  Christoph C Lees; Roberto Romero; Tamara Stampalija; Andrea Dall'Asta; Greggory A DeVore; Federico Prefumo; Tiziana Frusca; Gerard H A Visser; John C Hobbins; Ahmet A Baschat; Caterina M Bilardo; Henry L Galan; Stuart Campbell; Dev Maulik; Francesc Figueras; Wesley Lee; Julia Unterscheider; Herbert Valensise; Fabricio Da Silva Costa; Laurent J Salomon; Liona C Poon; Enrico Ferrazzi; Giancarlo Mari; Giuseppe Rizzo; John C Kingdom; Torvid Kiserud; Kurt Hecher
Journal:  Am J Obstet Gynecol       Date:  2022-01-10       Impact factor: 10.693

4.  The value of introducing cerebroplacental ratio (CPR) versus umbilical artery (UA) Doppler alone for the prediction of neonatal small for gestational age (SGA) and short-term adverse outcomes.

Authors:  Karla Leavitt; Linda Odibo; Chinedu Nwabuobi; Methodius G Tuuli; Anthony Odibo
Journal:  J Matern Fetal Neonatal Med       Date:  2019-07-21

5.  Biochemical tests of placental function versus ultrasound assessment of fetal size for stillbirth and small-for-gestational-age infants.

Authors:  Alexander Ep Heazell; Dexter Jl Hayes; Melissa Whitworth; Yemisi Takwoingi; Susan E Bayliss; Clare Davenport
Journal:  Cochrane Database Syst Rev       Date:  2019-05-14

6.  Fetal Doppler to predict cesarean delivery for non-reassuring fetal status in the severe small-for-gestational-age fetuses of late preterm and term.

Authors:  Ji Hye Jo; Yong Hee Choi; Jeong Ha Wie; Hyun Sun Ko; In Yang Park; Jong Chul Shin
Journal:  Obstet Gynecol Sci       Date:  2018-02-06

7.  Fractional fetal thigh volume in the prediction of normal and abnormal fetal growth during the third trimester of pregnancy.

Authors:  Louise E Simcox; Jenny E Myers; Tim J Cole; Edward D Johnstone
Journal:  Am J Obstet Gynecol       Date:  2017-06-23       Impact factor: 8.661

8.  The prediction of early preeclampsia: Results from a longitudinal proteomics study.

Authors:  Adi L Tarca; Roberto Romero; Neta Benshalom-Tirosh; Nandor Gabor Than; Dereje W Gudicha; Bogdan Done; Percy Pacora; Tinnakorn Chaiworapongsa; Bogdan Panaitescu; Dan Tirosh; Nardhy Gomez-Lopez; Sorin Draghici; Sonia S Hassan; Offer Erez
Journal:  PLoS One       Date:  2019-06-04       Impact factor: 3.240

9.  Reduced growth velocity across the third trimester is associated with placental insufficiency in fetuses born at a normal birthweight: a prospective cohort study.

Authors:  Teresa M MacDonald; Lisa Hui; Stephen Tong; Alice J Robinson; Kirsten M Dane; Anna L Middleton; Susan P Walker
Journal:  BMC Med       Date:  2017-08-31       Impact factor: 8.775

10.  Predicting intrapartum fetal compromise at term using the cerebroplacental ratio and placental growth factor levels (PROMISE) study: randomised controlled trial protocol.

Authors:  Helen Sherrell; Vicky Clifton; Sailesh Kumar
Journal:  BMJ Open       Date:  2018-08-13       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.